Investment Rating - The report rates the chemical industry as "Outperform" [1] Core Views - The report suggests focusing on undervalued leading companies in the industry, the impact of "anti-involution" on supply in related sub-industries, and the increasing importance of self-sufficiency in electronic materials companies and certain new energy materials companies amid price increases [1][9] Industry Dynamics - As of December 22-28, 2025, among 100 tracked chemical products, 34 saw price increases, 32 saw declines, and 34 remained stable. 55% of products had month-on-month average prices rising, while 35% fell, and 10% remained unchanged [8][27] - International oil prices remained stable, with WTI crude futures closing at $56.74 per barrel (up 0.14%) and Brent crude at $60.64 per barrel (up 0.28%) [28] - MDI prices slightly decreased, with pure MDI averaging 18,100 CNY/ton (down 4.23% week-on-week) and polymer MDI at 14,300 CNY/ton (down 2.39%) [29] - Acetic acid prices increased to 2,496 CNY/ton (up 2.93% week-on-week) [30] Investment Recommendations - As of December 27, 2025, the SW basic chemical industry P/E ratio (TTM excluding negative values) is 25.60, at the 76.58% historical percentile, while the P/B ratio is 2.33, at the 61.10% historical percentile. The SW oil and petrochemical industry P/E ratio is 13.17, at the 37.56% historical percentile, and the P/B ratio is 1.28, at the 36.98% historical percentile [9] - Recommendations include focusing on undervalued leading companies, the impact of "anti-involution" on supply, and the importance of self-sufficiency in electronic materials and certain new energy materials companies [9] - Long-term investment themes include expected demand recovery supported by policies, continuous optimization of supply, and the potential for performance and valuation improvements for leading companies [9] - Recommended stocks include Wanhua Chemical, Hualu Hengsheng, Satellite Chemical, and others [9]

Core Viewpoint - The company has decided to postpone the "Epoxy Propane Comprehensive Technology Renovation Project" due to delays in project construction and regulatory approvals, with the expected operational date now extended to June 30, 2026 [6][11][13]. Group 1: Fundraising Overview - The company raised a total of RMB 508.87 million through a private placement of 133,211,727 shares at RMB 3.82 per share, with a net amount of RMB 499.19 million after deducting issuance costs [2]. - The funds are to be used specifically for the "Epoxy Propane Comprehensive Technology Renovation Project," with a planned total investment of RMB 399.10 million, of which RMB 371.62 million will be funded by the raised capital [4][8]. Group 2: Project Delay Reasons - The delay in the project is attributed to increased regulatory requirements and longer safety evaluations, which have extended the construction timeline [5][10]. - Additional factors include unexpected difficulties in installation and adverse weather conditions during peak construction periods [10]. Group 3: Project Investment Adjustment - The investment estimate for the project has been revised to RMB 584.88 million, an increase of RMB 18.58 million from the original plan, with the shortfall to be covered by the company's own funds [7]. Group 4: Impact of Delay on Operations - The postponement of the project is expected to have no significant impact on the company's daily operations and aligns with the company's development needs [11][12]. - The company will maintain strict oversight of the use of raised funds and ensure compliance with relevant regulations [12]. Group 5: Board and Sponsor Opinions - The board of directors has approved the project delay, confirming that it does not affect the project's implementation, funding purposes, or scale [13][15]. - The sponsor institution has also expressed no objections to the delay, affirming that the decision adheres to regulatory requirements [14][15].

Core Viewpoint - Hongbaoli announced the approval of a proposal regarding the extension of fundraising project deadlines during its 11th Board of Directors' fourth meeting held on December 24 [2] Group 1 - The meeting took place in the conference room on the sixth floor of the comprehensive building [2] - The proposal concerning the extension of fundraising projects was reviewed and approved by the board [2]

证券代码：002165 证券简称：红宝丽 公告编号：临 2025－060 红宝丽集团股份有限公司 关于募集资金项目延期的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏 红宝丽集团股份有限公司（以下简称"公司"）于 2025 年 12 月 24 日召 开了第十一届董事会第四次会议，审议通过了《公司关于募集资金项目延期的议 案》，具体情况如下： 一、募集资金的基本情况 根据公司 2020 年第二次临时股东大会决议，并经中国证券监督管理委员会 证监许可[2021]509 号《关于核准红宝丽集团股份有限公司非公开发行股票的批 复》核准，公司于 2021 年 7 月向特定投资者非公开发行人民币普通股（A 股） 133,211,727 股，每股面值人民币 1.00 元，每股发行价为人民币 3.82 元。募集 资金总额为人民币 508,868,797.14 元，扣除发行费用（不含增值税）人民币 9,680,491.67 元，实际募集资金净额为人民币 499,188,305.47 元。上述募集资 金实际到账时间为 2021 年 7 月 30 日，存入公司募集资金专用账户。 ...

与会董事经审议，作出如下决议： 证券代码：002165 证券简称：红宝丽 公告编号：临 2025－059 红宝丽集团股份有限公司 第十一届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏 红宝丽集团股份有限公司（以下简称"公司"）第十一届董事会第四次会议 通知于 2025 年 12 月 19 日以书面及电子邮件方式发出，并通过电话确认。会议 于 2025 年 12 月 24 日在公司综合楼六楼会议室召开。会议应参会董事 9 名，实 际参会董事 9 名。公司高级管理人员列席了会议。会议召开符合《公司法》、《公 司章程》的相关规定。会议由董事长芮敬功先生主持。 一、审议通过了《公司关于募集资金项目延期的议案》；具体内容详见巨潮 资讯网（www.cninfo.com.cn）的相关公告。 表决结果：同意 9 票，反对 0 票，弃权 0 票 特此公告。 红宝丽集团股份有限公司董事会 2025 年 12 月 25 日 ...

募集资金投资项目延期的核查意见 关于红宝丽集团股份有限公司 中泰证券股份有限公司 中泰证券股份有限公司（以下简称"中泰证券""保荐机构"）作为红宝丽 集团股份有限公司（以下简称"红宝丽""公司"）持续督导阶段的保荐机构， 根据《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》《深圳 证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》等有关规定，对红宝丽部分募集资金投资项目延期的事 项进行核查并出具核查意见，具体情况如下： 一、募集资金基本情况 根据公司 2020 年第二次临时股东大会决议，并经中国证券监督管理委员会 证监许可[2021]509 号《关于核准红宝丽集团股份有限公司非公开发行股票的批 复》核准，公司于 2021 年 7 月向特定投资者非公开发行人民币普通股（A 股） 133,211,727 股，每股面值人民币 1.00 元，每股发行价为人民币 3.82 元。募集资 金总额为人民币 508,868,797.14 元，扣除发行费用（不含增值税）人民币 9,680,491.67 元，实际募集资金净额为人民币 499,188,305.47 元。上述 ...

Group 1 - The core issue of the announcement is that Hongbaoli Group and its executives received a warning letter from the Jiangsu Securities Regulatory Bureau for violations related to undisclosed non-operating fund occupation by related parties and inaccurate financial disclosures in annual reports [2][4] - Hongbaoli's violations include indirect provision of funds to its controlling shareholder through prepayments to suppliers, which were not disclosed in the 2022 and 2024 financial reports, despite the funds being fully recovered by the end of the year [4] - The company also reported inaccuracies in the procurement amounts from its top five suppliers in the 2021 and 2023 annual reports, indicating a lack of diligence from key executives, including the chairman and general manager [4] Group 2 - Hongbaoli's main business involves the manufacturing of chemical raw materials and products, specifically focusing on the research, production, and sales of propylene oxide and its derivatives, as well as polyurethane insulation boards, which are applied in energy-saving and environmental protection industries [5]

Group 1 - The Shenzhen Stock Exchange issued a regulatory letter to Hongbaoli Group Co., Ltd. regarding inaccurate disclosure of procurement amounts from top five suppliers in their 2021 and 2023 annual reports [1] - The company violated the Stock Listing Rules, specifically Articles 1.4 and 2.1.1, which require accurate and complete information disclosure [1] - As of the report date, Hongbaoli's market capitalization is 5.6 billion yuan, with revenue composition for the first half of 2025 being 90.52% from basic chemical raw materials, 9.4% from other businesses, and 0.09% from other industries [1]

一是2022年6月及2024年2月，红宝丽子公司分别以向供应商支付预付款的形式，间接向控股股东江苏宝 源投资管理有限公司(以下简称宝源投资)提供资金，构成关联方非经营性资金占用，相关款项于当年末 全部收回。公司未及时披露关联交易，也未在2022年半年报、2022年年报、2024年半年报、2024年年报 中对资金占用、关联交易情况进行披露。二是公司2021年及2023年年报中，关于前五名供应商采购金额 存在少计情况，信息披露不准确。 登录新浪财经APP 搜索【信披】查看更多考评等级 红宝丽(002165.SZ)公告，近日收到中国证券监督管理委员会江苏监管局下发的行政监管措施决定书 《江苏证监局关于对红宝丽集团股份有限公司、江苏宝源投资管理有限公司、芮敬功、芮益民、陈洪 明、陶梅娟采取出具警示函措施的决定》。决定书指出公司存在的问题： ...

证券代码：002165 证券简称：红宝丽 公告编号：临 2025－058 红宝丽集团股份有限公司关于 公司、第一大股东及相关人员收到江苏证监局警示函的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏 经查，红宝丽集团股份有限公司(以下简称红宝丽或公司)存在以下问题： 一是 2022 年 6 月及 2024 年 2 月，红宝丽子公司分别以向供应商支付预付款 的形式，间接向控股股东江苏宝源投资管理有限公司(以下简称宝源投资)提供资 金，构成关联方非经营性资金占用，相关款项于当年末全部收回。公司未及时披 露关联交易，也未在 2022 年半年报、2022 年年报、2024 年半年报、2024 年年报 中对资金占用、关联交易情况进行披露。二是公司 2021 年及 2023 年年报中，关 于前五名供应商采购金额存在少计情况，信息披露不准确。 红宝丽上述行为违反了《上市公司信息披露管理办法》(证监会令第 182 号， 以下简称《信披办法》)第三条第一款、第十四条第十项、第十五条第七项、第二 十二条第一款及第二款第一项，《公开发行证券的公司信息披露内容与格式准则第 2 号— ...